Abualbishr Alshreef BPharm, MPH, MSc

Abu1

Research Associate

HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 1017

Tel: (+44) (0)114 222 20673
Fax: (+44) (0)114 222 0749

E-mail: a.o.alshreef@sheffield.ac.uk

ORCiD: 0000-0003-2737-1365

Biography

I joined ScHARR (HEDS) as a Research Associate in Health Economics and Decision Modelling in December 2014 after completing an MSc in Health Economics at the University of York in 2014. For my MSc, I undertook a summer placement at the Centre for Health Economics (CHE) at University of York. My research project at CHE was focused on methods to account for follow-up time differences when calculating QALYs from randomised controlled trials.
Prior to this, I worked for the health insurance and pharmaceutical industries. My work was mainly focused on applied research, market access and pharmaceuticals reimbursement decisions.

Research interests

  • Economic evaluations alongside clinical trials
  • Decision analytic modelling for cost-effectiveness analysis
  • Early-stage economic evaluation of medical devices and other innovations

Teaching Interests

My teaching interests are economic evaluation and quantitative research methods. I am currently facilitating small group tutorials on the Masters of Public Health programmes on two modules:
HAR687: Economic Evaluation and Health Care Financing
HAR6030: Introduction to Research Methods

Professional activities

  • Co-lead on internationalisation in HEDS, and member of ScHARR's internationalisation committee
  • Member of the UK Health Economists’ Study Group (HESG)
  • Member of International Society for Pharmacoeconomics and Outcome Research (ISPOR)

Current projects

  • Economic Evaluation of quality improvement programme aimed at reducing dispensing errors in community pharmacies
  • Economic Evaluation of dementia service redesign across Leeds: a return on investment (ROI) analysis
  • Review of Economic submissions to NICE’s Medical Technologies Evaluation Programme
  • A multicentre double-masked randomised non-inferiority clinical trial comparing the clinical and cost-effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion (LEAVO)
  • The HubBLe Trial: Haemorrhoidal Artery Ligation (HAL) versus Rubber Band Ligation (RBL) for symptomatic second and third degree haemorrhoids: A multi-centre randomised controlled trial
  • IPSU - Impact of physiotherapy on sexual function and a comparison of standard versus electrical stimulation: a randomised controlled trial

Journal articles

Conference proceedings papers